Efficacy and safety of the PHIL embolic agent in the treatment of intracranial dural arteriovenous fistulas: results of the PHIL-dAVF study.
Marnat G, Barreau X, Januel AC, Spelle L, Piotin M, Mounayer C, Borota L, González A, Casasco A, Keston P, Lobotesis K, Cronqvist M, Holtmannspötter M, Guimaraens L, Boccardi E, Valvassori L, Espinosa de Rueda M, Cognard C; PHIL-dAVF study investigators.
Marnat G, et al. Among authors: gonzalez a.
J Neurointerv Surg. 2025 Jan 8:jnis-2024-022630. doi: 10.1136/jnis-2024-022630. Online ahead of print.
J Neurointerv Surg. 2025.
PMID: 39778931